Immediate Impact

32 hit
Sub-graph 1 of 12

Citing Papers

Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update
2024 Hit
Management of chronic myeloid leukemia in 2023 – common ground and common sense
2023 Hit
2 intermediate papers

Works of Yıldız Aydın being referenced

Real-Life Data and a Single Center Experience on Dasatinib-Induced Pulmonary Arterial Hypertension in Patients with Philadelphia Chromosome-Positive Leukemias
2015
Chronic myeloid leukemia patients who develop grade I/II pleural effusion under second-line dasatinib have better responses and outcomes than patients without pleural effusion
2014
and 1 more

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Yıldız Aydın 74 60 60 28 25 39 174
Hee‐Jo Baek 41 0.6× 48 0.8× 42 0.7× 32 1.1× 15 0.6× 36 278
Hiraku Mori 144 1.9× 12 0.2× 91 1.5× 22 0.8× 19 0.8× 23 219
Guangxin Peng 140 1.9× 35 0.6× 63 1.1× 21 0.8× 2 0.1× 50 237
Alessandra Ricco 185 2.5× 9 0.1× 117 1.9× 28 1.0× 25 1.0× 29 277
Anke Fähnrich 21 0.3× 19 0.3× 25 0.4× 34 1.2× 37 1.5× 28 250
Koviljka Krtolica 38 0.5× 23 0.4× 24 0.4× 84 3.0× 14 0.6× 25 256
Meltem Kurt Yüksel 79 1.1× 9 0.1× 44 0.7× 55 2.0× 3 0.1× 60 210
Elisabet Lloveras 29 0.4× 31 0.5× 57 0.9× 22 0.8× 6 0.2× 20 250
MILTON S. SACKS 65 0.9× 6 0.1× 35 0.6× 6 0.2× 38 1.5× 22 229
Shun‐Ping Chang 49 0.7× 33 0.6× 20 0.3× 44 1.6× 4 0.2× 41 278

All Works

Loading papers...

Rankless by CCL
2026